rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Kamada Ltd. -

KMDA · Nasdaq

Health CareBiotechnologyNot moving yet

KMDA stood above a rising 150-day average in 25 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 0.3% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 4
Industry in uptrend
18% -14 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$3.3M
Officials’ trades on record
0
Institutions holding
47 (+9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 25 of 52 weeks.

21 Apr – 20 Oct
18%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$3.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months4
Buyers · sellers0 · 1
WhoDidSharesTraded
David TsurDirectorsold22,827at $8.1814 Sep 2026filed 17 Sep 2026
David TsurDirectorsold175at $8.269 Sep 2026filed 11 Sep 2026
David TsurDirectorsold162,760at $8.268 Sep 2026filed 11 Sep 2026
David TsurDirectorsold14,238at $8.287 Sep 2026filed 11 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders47+9 on the quarter
New · exited13 · 4
Reported value$35.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Phoenix Financial Ltd.unchanged · filed 11 Aug 20261,654,952$12.1M00.0%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026742,418$5.4M-20,530−2.7%
DIMENSIONAL FUND ADVISORS LPnew · filed 11 Aug 2026301,680$2.2M+301,680
ARK Investment Management LLCreduced · filed 14 Aug 2026263,304$1.9M-6,253−2.3%
Huntleigh Advisors, Inc.added · filed 4 Aug 2026162,644$1.2M+7,188+4.6%
TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 2026151,100$1.1M-43,145−22.2%
RENAISSANCE GROUP LLCreduced · filed 13 Aug 2026124,896$917K-1,005−0.8%
MARSHALL WACE, LLPreduced · filed 13 Aug 202675,182$552K-74,811−49.9%
Man Group plcadded · filed 14 Aug 202661,889$454K+7,131+13.0%
GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 202659,046$433K-13,909−19.1%
31 Mar 2023 – 30 Jun 2026
183246Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

David Tsur Company insiderDirector · last 14 Sep 20260 · 4
Nir Livneh Company insiderVP, General Counsel · last 14 Sep 20260 · 0
Yael Brenner Company insiderVP Quality · last 14 Sep 20260 · 0
Amir London Company insiderChief Executive Officer · last 27 Aug 20260 · 0
Assaf Itshayek Company insiderDirector · last 27 Aug 20260 · 0
Benjamin Dekel Company insiderDirector · last 27 Aug 20260 · 0
Boris Gorelik Company insiderVP, BD and Strategic Programs · last 27 Aug 20260 · 0
Chaime Orlev Company insiderChief Financial Officer · last 27 Aug 20260 · 0
Eran Nir Company insiderVP, Operations · last 27 Aug 20260 · 0
Hanni Neheman Company insiderVP, Marketing & Sales · last 27 Aug 20260 · 0
Ishay Davidi Company insiderDirector, 10% owner · last 27 Aug 20260 · 0
Karnit Goldwasser Company insiderDirector · last 27 Aug 20260 · 0

Same industry

MRNA ModernaLeading+167%
ENTX Entera BioLeading+52%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 31 Dec 20250.3%

Analyst forecasts

No analyst forecasts yet.